Dosage Form: Oil solution for Injection
Pharmacotherapeutic group: Androgens. ATC code G03BA03.
Androgenic substance, composed of ester of testosterone cypionate. Depending on the metabolic and hormonal levels, the average period of substance effectiveness is 15-16 days. It affects the development and function of the external genitalia, prostate, seminal vesicles, and secondary sexual characteristics (voice, hair growth). Participates in the formation of the constitution of the body and sexual behavior, stimulates the libido and potency, stimulates spermatogenesis. Is an antagonist of female sex hormones – estrogen. Has anabolic effect which manifests itself in stimulating protein synthesis, the delay required for the synthesis of protein, potassium, sulfur, phosphorus, strengthen the fixation of calcium in the bones and increase lean body mass. If sufficient protein diet stimulates erythropoietin
Indications for REFERENCE:
Replacement therapy in primary and secondary hypogonadism, eunuchoidism; impotence endocrine genesis, post-castration syndrome; male menopause; oligospermia; osteoporosis caused by androgen deficiency. Hormone-dependent tumors in women – breast cancer and menopausal disorders in women (with estrogen) and functional bleeding Hyperestrogenism; uterine fibroids.